A recent midstage study found that LSD reduced symptoms of anxiety in patients with generalized anxiety disorder, with benefits lasting up to three months.

▶ LISTEN TO ORLANDO’S MORNING NEWS EXPRESS PODCAST ON WDBO

The study, conducted by drugmaker Mindmed, tested various doses of LSD and plans to seek FDA approval based on the positive results.

“Ours is the first modern trial to look specifically at LSD, or any psychedelic, for generalised anxiety disorder,” says Dan Karlin at biotech company MindMed in New York.

READ: Preterm birth linked to higher blood pressure and anxiety in adults

The research marks a revival of interest in psychedelics for therapeutic purposes, with LSD being designated as a potential breakthrough therapy alongside other psychedelics like psilocybin and MDMA.

READ: Study ranks most stressed cities

While the study showed promising results, further research is needed to address issues such as patient preparation and long-term benefits.

Click here to download our free news, weather and traffic app. And click here to subscribe to our daily 3 Big Things newsletter.